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Abstract
Background: MiR-1 (microRNA-1) has been used as a positive control in some microRNA experiments. We found
that miR-1 transfection of nasopharyngeal carcinoma cells reveals a typical apoptotic process as shown by time-
lapse microscopy so we investigated the mechanisms of miR-1 inducing apoptosis.
Methods: To confirm that miR-1 induces apoptosis, we used Annexin V and TUNEL staining and caspase assay. To
determine that miR-1 directly targets genes that involve in apoptosis, we analyzed microRNA and pathway
databases, and cDNA expression microarrays from miR-1 transfected cells. To demonstrate candidate miR-1
targeted genes, we used qRT-PCR analysis and luciferase reporter vector assays. To assess the miR-1 target gene
PTMA (prothymosin alpha, ProTalpha) involves in apoptosis, we used PTMA siRNA to knock down PTMA.
Results: Annexin V and TUNEL staining and caspase assay confirm that miR-1 induces nasopharyngeal carcinoma
cell apoptosis. MiR-1 transfection of HeLa, Cal-27, KYSE30 and NPC-TW06 cell lines which express low levels of
endogenous miR-1 also induces apoptosis. However, miR-1 transfection of cell lines such as SW620, HepG2, HEK-
293T, SAS and PC-13 which express high levels of endogenous miR-1 does not result in apoptosis. MiR-1 directly
targets PTMA gene. PTMA siRNA and miR-1 accelerate the apoptotic process in cells treated with apoptosis
inducers.
Conclusions: The exogenous expression of miR-1 induces apoptosis in a number of cell lines. This is a model of
microRNA-induced cell apoptosis. The PTMA is one of miR-1 target genes which involve in miR-1 inducing
apoptosis. The apoptotic inducers including actinomycin D, camptothecin and etoposide are also the
chemotherapeutic drugs in clinical cancer therapy and PTMA siRNA can accelerate apoptotic progression in cells
treated with those apoptosis inducers. Therefore PTMA siRNA may have potential applications as an adjuvant in
cancer chemotherapy.
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Background
MicroRNAs are endogenous non-coding RNAs that are
approximately 21 nucleotides long. They are evolutiona-
rily conserved and found in many animals, plants, fungi
and viruses. MicroRNAs function as regulators of gene
expression and play important roles in biological pro-
cesses [1,2]. In previous investigation of pathogenic
microRNAs in nasopharyngeal carcinoma (NPC) cells,
we used miR-1 (microRNA-1) to transfect NPC cells as
a positive control. To our surprise, we observed a typical
apoptotic response in miR-1 transfected NPC cells with
time-lapse microscopy. Negative control microRNA and
other microRNAs did not induce cellular apoptosis
under identical transfection conditions. Transfection of
miR-1 also caused apoptosis in other cancer cell lines
such as HeLa, Cal-27 and KYSE30.
Apoptosis is a form of spontaneous cell death charac-
terized by externalization of phosphatidylserine, cell
shrinkage, chromatin margination and condensation,
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budding and production of apoptotic bodies [3,4]. Apop-
tosis is one of the important biological processes for
organisms. Many diseases have been associated with
abnormal apoptosis; excessive apoptosis has been linked
to auto-immunity and insufficient apoptosis plays a
large role in cancer transformation.
In the present study, we confirm that miR-1 directly
targets PTMA mRNA. PTMA also known as prothymo-
sin-alpha or ProTalpha is a hormone or hormone-like
polypeptide precursor first isolated from the rat thymus
gland [5]. PTMA functions in transcription regulation
and cell proliferation [6,7], and acts as an apoptotic
inhibitor by binding to Apaf-1 [8,9]. This study shows
that PTMA siRNA and miR-1 accelerate the apoptotic
process in cells treated with apoptotic inducers in com-
parison to the control. Hence the PTMA siRNA and
miR-1 may have a potential therapeutic application for
cancer therapy.
Methods
Cell lines
The following cell lines were used for this study: HeLa,
human cervical adenocarcinoma [ATCC CCL-2.2], Cal-
27, human tongue carcinoma [ATCC CRL-2095 ],
KYSE30, human esophageal carcinoma [JCRB0188 ],
HepG2, human hepatocellular carcinoma [ATCC HB-
8065 ], PC13, human lung large cell carcinoma [IBL],
SW620, human colorectal adenocarcinoma [ATCC
CCL-227 ], SAS, human tongue carcinoma [JCRB0260 ],
HEK-293T, human transformed embryonal epithelial
cell [ATCC CRL-11268 ], NPC-TW01 and NPC-TW06
were human nasopharyngeal carcimoma that were
established in our laboratory [10-12]. All cell lines were
cultured in DMEM containing 5% fetal calf serum and
L-glutamine and incubated in a 10% CO2 incubator.
Transfection of microRNA and siRNA
T h em i c r o R N A si nt h i ss t u d yw e r ep u r c h a s e df r o m
Ambion (Austin, TX, USA); the microRNAs included
Pre-miR™ hsa-miR-1 miRNA precursor positive control
(Cat# AM17150), Pre-miR™ hsa-miR-486 miRNA pre-
cursor (Cat# PM10546), Pre-miR™ hsa-miR-429
miRNA precursor (Cat# PM10221), Pre-miR™ hsa-miR-
200a miRNA precursor (Cat# PM10991) and Pre-miR™
miRNA precursor negative control #1 (Cat# AM17110).
At o t a lo f1 . 5×1 0
5 cells were seeded in each well of a
6-well culture plate in 1 ml of normal culture medium
for microRNA transfection. The microRNA transfection
mixture was prepared by diluting 1 μlo f5 0μMm i c r o -
RNA in 100 μl of Opti-MEM I reduced serum medium
(GIBCO, Gaithersburg, MD, USA). A total of 6 μlo f
HiPerFect transfection reagent (QIAGEN, Valencia, CA,
USA) was added to the diluted microRNA and mixed by
vortexing. After incubation for 10 minutes at room tem-
perature, normal culture medium was added to mixture
to bring the final volume to 1 ml. The microRNA trans-
fection mixture was added to the well containing cells
and mixed gently. A mock-transfected control was pre-
pared by the same process but without the addition of
microRNA. Another untransfected control (blank) was
also prepared by the same process but without the addi-
tion of microRNA and transfection reagent. The culture
medium in all experimental groups was changed after
24 hours to the regular medium and transfected again.
The siRNA transfection conditions of PTMA Pre-design
ChimeraRNAi (Abnova Cat# H00005757-R01, Taipei,
Taiwan) and AllStars negative control siRNA (QIAGEN
Cat#1027281) were identical to those for the microRNA
transfection.
Apoptosis assay
The morphological features of cell apoptosis were
observed by ASTEC CCM-MULTI time-lapse micro-
scopy (ASTEC, Fukuoka, Japan). Phosphatidylserine was
stained using an Annexin V FITC assay kit (Serotec,
Raleigh, USA). DNA fragments were stained using a
DeadEnd Fluorometric TUNEL system (Promega, Madi-
son, WI, USA). Caspase activity was detected by a Cas-
pase-Glo caspase 3/7 assayk i t( P r o m e g a )a n dZ - V A D -
FMK caspase inhibitor (Promega). All of the experimen-
tal processes were performed according to manufacturer
instructions.
Microarray analysis
NPC-TW01 and HeLa cells were transfected with miR-1
and miR-negative control and transfected again after 24
hours. Total RNA was extracted using Trizol (Invitrogen,
Gaithersburg, MD, USA) after 42 hours. Total RNA from
the miR-1 transfected cells was labeled with Cy5; total
RNA from the miR-negative transfected cells was labeled
with Cy3. The Cy-labeled RNAs were hybridized to a
human whole genome oligo 4 × 44 K microarray (Agilent,
Santa Clara, CA, USA). After washing and drying, the
microarrays were processed with the Agilent microarray
scanner; microarray data were analyzed by the GeneSpring
GX 11 and Ingenuity Pathways analysis system. All micro-
array experiments were performed according to Agilent
protocols. The microarray data had been submitted to
NCBI GEO (http://www.ncbi.nlm.nih.gov/geo) under the
accession numbers GSM706489 and GSM706490.
Quantitative RT-PCR
For mRNA quantification, total RNA was extracted by
Trizol (Invitrogen) and reverse transcribed by Super-
script III (Invitrogen). The quantitative real-time poly-
merase chain reaction (qRT-PCR) experiments were
performed using the ABI Power SYBR Green PCR Master
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Biosystems, Austin, TX, USA). All of the experimental
protocols were performed according to the manufacturer’s
instructions. qRT-PCR primer sequences are comprehen-
sively listed in table 1. For endogenous miR-1 quantifica-
tion, microRNA was reverse-transcribed using a TaqMan
MicroRNA reverse transcription kit (Applied Biosystems,
Cat#4366597) and primers using the TaqMan endogenous
controls RNU6B (Applied Biosystems, Cat#4373381) and
TaqMan MicroRNA assays hsa-miR-1 (Applied Biosys-
tems, Cat#4373161). Remaining procedures were per-
formed identically to mRNA quantification.
Luciferase reporter assay
DNA fragments of miR-1 binding sites (wild-type and
mutant) in the PTMA 3’UTR were synthesized and
cloned into the multiple cloning sites (SacI-XbaI) of
pmirGLO vector (Promega). All constructions were con-
firmed by DNA sequencing. The constructions were co-
transfected with or without miR-1 into NPC-TW01 cells.
Luciferase activity was measured 36 hours after transfec-
tion using the Dual-Glo luciferase assay system (Pro-
mega) and Orion II microplate luminometer (Berthold,
Bad Wildbad, Germany). All experimental protocols were
performed according to the manufacturer’si n s t r u c t i o n s .
DNA fragment sequences are list in table 2.
Treatment of apoptotic inducers
For assessing the apoptotic effects of PTMA siRNA or
miR-1, a total of 5 × 10
3 NPC-TW01 cells were seeded
in each well of a 96-well culture plate and were trans-
fected with PTMA siRNA, miR-1 or control as men-
tioned above. After transfection for 48 hours,
actinomycin D apoptotic inducer was added to the cul-
ture media to a final concentration of 5 μM (or camp-
tothecin 10 μM, or etoposide 200 μM). Cells were
subsequently observed by time-lapse microscopy
(ASTEC, Fukuoka, Japan). Another 96 well plates
(which experimental conditions were identical to that
plate for time-lapse microscopy observation) were per-
formed MTT assay for quantitating cell viability.
Results
MiR-1 induces NPC cell apoptosis
NPC-TW01 cells were transfected with either miR-1 or
control and observed by time-lapse microscopy. The
miR-1 transfected cells appeared to undergo apoptosis
as only 12% of cells survived after transfection for 150
hours; the majority of the cells transfected with control
survived (Figure 1A, 1B). The miR-1 transfected cells
displayed typical apoptotic morphology, including cell
shrinkage and budding of apoptotic bodies (Figure 1C).
Further analysis by Annexin V staining (Figure 2) and
TUNEL assay (Figure 3) revealed that there were more
apoptotic cells in sample transfected with miR-1 than
sample transfected with control. We used the Promega
Caspase-Glo caspase 3/7 assay kit to measure caspase 3/
7 activities in the NPC-TW01 cells transfected with
miR-1. 48 hours after transfection, for miR-1 transfected
cells demonstrated a 4.6-fold increase in caspase 3/7
activities compared to the untransfected cells (p < 0.01).
A subset of the NPC-TW01 cells was treated 50 μMo f
the broad-spectrum Promega Z-VAD-FMK caspase inhi-
bitor for 1 hour before transfection with miR-1. After
120 hours of miR-1 transfection, a MTT assay deter-
mined the viability of the cells treated with caspase inhi-
bitor was 2.5-fold higher compared to the cells not
treated with caspase inhibitor (p < 0.01). MiR-1 trans-
fection of NPC-TW01 cells induced apoptosis, whereas
NPC-TW01 cells transfected with other microRNAs
(miR-200a, miR-429 and miR-486) did not induce cellu-
lar apoptotic morphology as observed by time-lapse
Table 1 Primers used for qRT-PCR
Name Symbol Entrez Gene ID Sequences (5’ to 3’)
C5-QF C5 NM_001735 CGGTGCTGGAGTTTAATGTCAA
C5-QR C5 NM_001735 TGGCTGAGAGATGAGTATGCTATTG
CARD8-QF CARD8 NM_001184900 TTTCTCAGGTGCAGCCTTTG
CARD8-QR CARD8 NM_001184900 CTCCACCAGCTCCTTCTCAT
FAIM-QF FAIM NM_018147 ACAGCGGGTGAGTTTGTAGA
FAIM-QR FAIM NM_018147 CTTCCCACTACTGACAGCCT
GRIN2A-QF GRIN2A NM_001134408 GACAAGGATCCGACGTCTACCT
GRIN2A-QR GRIN2A NM_001134408 GCATGACCGTGGCTTGCT
PTMA-QF PTMA NM_002823 CGAAATCACCACCAAGGACTT
PTMA-QR PTMA NM_002823 GTCAGCCTCCTGCTCCC
TP63-QF TP63 NM_001114982 GCAGTTGTGTTGGAGGGATGA
TP63-QR TP63 NM_001114982 CCCATCTCTGGTTTCCAGAGTAAC
GAPDH-QF GAPDH NM_002046 GCACCGTCAAGGCTGAGAA
GAPDH-QR GAPDH NM_002046 AGGGATCTCGCTCCTGGAA
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into HeLa, Cal-27, KYSE30, and NPC-TW06 cells gen-
erated apoptotic bodies but these changes in morphol-
ogy did not occur after transfection of SW620, HepG2,
SAS, HEK-293T and PC-13 cell (data not shown). The
endogenous expression of miR-1 in different cell lines
was analyzed by qRT-PCR. The endogenous miR-1
expression level in NPC-TW01 cells was used as a stan-
dard for comparison. Cells with low endogenous miR-1
expression levels (Cal-27 = 0.01-fold, KYSE30 = 0.13-
fold, HeLa = 0.04-fold, and NPC-TW01 = 1-fold) could
be induced to undergo apoptosis via miR-1 transfection;
cells with high endogenous miR-1 expression levels
(SW620 = 155-fold, HEK-293T = 86.9-fold, HepG2 =
2.6-fold, SAS = 3-fold, and PC-13 = 9.7-fold) could not
be induced to undergo apoptosis by miR-1 transfection.
MiR-1 directly targets PTMA
To investigate the mechanisms of miR-1-induced apop-
tosis, we performed a cDNA expression microarray ana-
lysis. We then screened microRNA database and
pathway database to identify the candidate miR-1-tar-
geted genes involved in apoptosis. During a 42-hour
transfection of NPC-TW01 and HeLa cells with miR-1
or miR-negative control total RNA was isolated from
the cells and hybridized to an Agilent human whole
genome oligo 4 × 44 K microarray. Using GeneSpring
GX 11 (microarray analysis software) to compare the
mRNA expression profiles between miR-1 and miR-
negative transfected cells, a total of 2473 transcripts
were found to be down regulated over two-fold in NPC-
TW01 cells. A total of 2063 transcripts were found to
be down regulated more than two-fold in HeLa cells. To
rule out cell-line-specific expression transcripts, we
combined the NPC-TW01 and HeLa cells down regu-
lated transcripts and obtained 279 transcripts. The 279
transcripts were compared to the miR-1 predictive tar-
geting genes from the miRTarBase (http://mirtarbase.
mbc.nctu.edu.tw) and miRecord database (http://mire-
cords.biolead.org). A tot a lo f8 6t r a n s c r i p t sw e r e
identified as targets of miR-1. The 86 transcripts were
further analyzed with the Ingenuity pathways analysis
system (http://www.ingenuity.com). From Ingenuity
pathways database analysis; the down regulation of six
transcripts (C5, CARD8, FAIM, GRIN2A, PTMA, and
TP63) could increase apoptosis (Table 3). To verify if
the six transcripts are regulated by miR-1 in other cell
lines, nine different cell lines were transfected with or
without miR-1; mRNA levels of the six candidate genes
were quantitated by qRT-PCR. The PTMA (prothymo-
sin alpha, ProTalpha) transcript was down regulated in
all nine cell lines during miR-1 transfection (Table 4).
Therefore, we focused on PTMA and performed a luci-
ferase reporter vector assay to determine if miR-1 can
directly regulate PTMA expression. The miR-1 binding
site (predict by miRanda) was inserted into the reporter
vector and co-transfected with or without miR-1 into
NPC-TW01 cells. The luciferase activity of miR-1 trans-
fected cells was significantly decreased compared to that
of cells not transfected with miR-1. However, if the
reporter vector bore the mutated miR-1 binding site and
was co-transfected with or without miR-1, the luciferase
activity was not significantly distinguishable while com-
paring miR-1 transfected and untransfected cells (Figure
4). All data indicate that miR-1 impairs PTMA mRNA
expression by directly binding to the PTMA mRNA 3’-
UTR in NPC-TW01 cells.
PTMA siRNA assists cells progression to apoptosis
Propelling by evidence that miR-1 induces apoptosis and
directly knocks down PTMA mRNA expression; we
investigated the role of PTMA in apoptosis by transfect-
ing NPC-TW01 cells with PTMA siRNA. There was no
difference in apoptotic morphology between PTMA
siRNA and control transfected cells as observed by
time-lapse microscopy (data not shown). In fact, trans-
fection of NPC-TW01 cells with PTMA siRNA knocked
down PTMA mRNA expression 0.027-fold (p <0.01)
relative to untransfected control cells; mRNA expression
was analyzed by qRT-PCR after transfecting for 24
Table 2 Oligonucleotides used for pmirGLO luciferase reporter vector construction
Name Sequences(5’ to 3’)
PTMA#1-wt-se ACGAGCTCTTGTATTTTTTATTTACATTTTATCTAGAG
PTMA#1-wt-as CTCTAGATAAAATGTAAATAAAAAATACAAGAGCTCGT
PTMA#1-mut-se ACGAGCTCTTGTATTTTTTATTATGTAATTATCTAGAG
PTMA#1-mut-as CTCTAGATAATTACATAATAAAAAATACAAGAGCTCGT
PTMA#2-wt-se ACGAGCTCAAACAATCTTATTCCGAGCATTCCATCTAGAG
PTMA#2-wt-as CTCTAGATGGAATGCTCGGAATAAGATTGTTTGAGCTCGT
PTMA#2-mut-se ACGAGCTCAAACAATCTTATTCCGAGGTAAGGATCTAGAG
PTMA#2-mut-as CTCTAGATCCTTACCTCGGAATAAGATTGTTTGAGCTCGT
pmirGLO-sequencing-primer TGAAGAGCCTGATCAAATAC
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Figure 1 Transfection of miR-1 into NPC-TW01 cells induces apoptosis. From left to right: untransfected NPC-TW01 cells (blank), transfection
reagent only (mock), transfection reagent and miR-negative control (miR-negative), and transfection reagent and miR-1 (miR-1). Photos were
taken by time-lapse microscopy 150 hours after transfection. (B) MTT assay after transfection with miR-1 for 150 hours. Most miR-1 transfected
cells were dead (12% cell viability), whereas only a few control transfected died. (***Comparison between two groups as indicated, p < 0.001.
Error bars correspond to mean ± SD) (C) The process of apoptotic body budding was visualized by time-lapse microscopy in miR-1 transfected
cells. The time above each photograph represents the specific time that NPC-TW01 cells were transfected with miR-1.
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mRNA expression alone does not induce apoptosis. We
propose that the apoptosis mechanism involves the
down regulation of apoptotic inhibitors and up regula-
tion of apoptotic inducers. Because PTMA has pre-
viously been reported as an apoptotic inhibitor [8,9], we
performed another siRNA experiment in which NPC-
TW01 cells were transfected with PTMA siRNA or
miR-1. After transfection for 48 hours, apoptotic indu-
cer actinomycin D was added to the culture media. Cell
viability was evaluated by MTT assay and cell morphol-
ogy was observed by time-lapse microscopy. As shown
in figure 5, apoptosis appeared earlier in the PTMA
siRNA and miR-1 transfected cells treated with actino-
mycin D relative to control transfected cells. Treating
cells with other apoptotic inducers such as camptothe-
cin and etoposide produced the same results as those of
actinomycin D (data not shown). These results indicate
that knock down of PTMA expression alone does not
induce apoptosis. However, PTMA siRNA and miR-1
transfections in conjunction with the addition of apop-
totic inducers accelerate the apoptotic process in NPC-
TW01 cells.
Discussion
MiR-1 can be used as a positive control and for optimiz-
ing transfection conditions in microRNA experiments (e.
g., Ambion Pre-miR miRNA Starter Kit, QIAGEN Syn-
hsa-miR-1 miScript miRNA mimic positive control). In
this study, we noticed that transfection of NPC-TW01
and other cancer cell lines with exogenous miR-1 induce
cell apoptosis. Endogenous miR-1 expression may be
linked to apoptosis; for example, myocardial infarction
increases miR-1 expression and induces apoptosis in rat
 
Figure 2 Annexin V analysis of apoptotic cells. Untransfected NPC-TW01 cells (blank), transfection reagent only (mock), transfection reagent
and miR-negative control (miR-negative), and transfection reagent and miR-1 (miR-1) separately. After transfection for 90 hours, the cells were
stained by annexin V and propidium iodide and detected by flow cytometry. The percentage of cells stained in each quadrant is listed in the
corner of each quadrant. The upper left quadrants represent oncosis cells, lower left quadrants represent normal cells, upper right quadrants
represent necrotic cells (late apoptotic or oncotic cells) and lower right quadrants represent early apoptotic cells.
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Symbol Entrez Gene Name Entrez Gene ID Fold change in NPC-TW01 Fold change in HeLa
C5 complement component 5 727 -2.96 -2.36
CARD8 caspase recruitment domain family, member 8 22900 -4.74 -2.72
FAIM Fas apoptotic inhibitory molecule 55179 -4.28 -2.54
GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A 2903 -2.54 -2.31
PTMA prothymosin, alpha 5757 -6.62 -2.76
TP63 tumor protein p63 (TP73L) 8626 -2.37 -2.33
NPC-TW01 and HeLa cells were transfected with miR-1 and their total RNA was hybridized to microarrays. Transcripts that were down regulated more than two-
fold were screened as target genes of miR-1 using the miRTarBas and miRecord databases. The target genes were then screened for involvement in apoptosis
using the Ingenuity pathways database.
 
Figure 3 TUNEL assay of the fragmented DNA from apoptotic cells. Clockwise from top left: untransfected NPC-TW01 cells (blank),
transfection reagent only (mock), transfection reagent and miR-1 (miR-1) and transfection reagent and miR-negative control (miR-negative). After
transfection for 120 hours, the cells were subjected to TUNEL assay. TUNEL-stained cells were quantitated by flow cytometry. The number in
each panel is the percentage of TUNEL-positive cells.
Table 4 qRT-PCR confirming miR-1 down regulates genes in different cell lines
Symbol\cell NPC-TW01 NPC-TW06 HEK-293T Cal-27 HeLa HepG2 KYSE30 SAS SW620
C5 0.16 0.71 0.19 0.44 0.21 0.24 0.32 0.11 1.53
CARD8 0.44 0.94 0.17 0.63 1.04 0.31 0.04 0.58 0.71
FAIM 0.22 0.88 0.21 0.62 0.80 0.29 0.44 0.21 1.32
CRIN2A 1.05 0.19 0.09 1.36 0.43 0.24 0.80 1.51 0.31
PTMA 0.29 0.28 0.28 0.26 0.45 0.45 0.42 0.11 0.62
TP63 0.69 1.12 0.07 2.45 0.92 0.27 1.00 0.88 0.43
Nine cell lines were transfected with or without miR-1; total RNA was isolated from these cells after 24 hours of transfection. mRNA from the six candidate genes
were quantitated by qRT-PCR, normalized to GAPDH mRNA, and compared to levels in the untransfected samples. PTMA mRNA is down regulated in all nine
miR-1 transfected cell lines.
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Page 7 of 10H9C2 myoblast cells [13,14]. MiR-1 expression also
increases and apoptosis is induced when rat cardio-
myoctes are incubated with H2O2 [15] and treated with
high glucose [16,17]. The mir-1-1 gene is methylated
and has reduced expression in human hepatocellular
carcinoma cell lines compared to normal liver cells.
When the mir-1-1 gene is hypomethylated, it re-
expresses miR-1 and can induce apoptosis [18]. In
mouse myoblast cells, the mutation of MyoD transcrip-
tion factors down regulates miR-1 expression and
decreases cell apoptosis [19]. MiR-1 expression is down
regulated in human lung cancer tissues and cell lines in
comparison to levels in normal human lungs. MiR-1
affects lung cancer cells in response to anti-cancer drugs
[20]. MiR-1 is down regulated in human bladder cancer
[21] and head-neck squamous cell carcinoma (HNSCC)
cells [22]. Microarray gene expression profiles of miR-1
transfected cells revealed 17 miR-1 targeted candidate
genes, they included PTMA. The authors demonstrated
that miR-1 directly targets TAGLN2 and acts as a
tumor suppressive microRNA [21,22]. All reports in
existing literature indicate that miR-1 plays an impor-
tant role in apoptosis and cancer pathogenesis. In this
study, we show that cell lines with low levels of endo-
genous miR-1 expression were apoptosis inducible via
transfection with miR-1. Cell lines with high endogen-
ous miR-1 expression were not apoptosis inducible by
transfection with miR-1. Further testing with more cell
lines is needed to obtain a definitive conclusion. MiR-1
directly down regulates PTMA mRNA levels and
induces apoptosis. We used PTMA siRNA to down reg-
ulate PTMA mRNA levels and observed whether PTMA
siRNA could induce apoptosis. Knocking down PTMA
expression alone did not induce apoptosis but acceler-
ated apoptotic progression in cells treated with apopto-
sis inducers. These results are in correlation with
previous reports that PTMA is an apoptotic inhibitor
and has anti-apoptotic properties [9,23,24]. The anti-
apoptotic mechanism is that PTMA binds to Apaf-1
then prevents Apaf-1/cytochrome C apoptosome forma-
tion. Without apoptosome formation, pro-caspase-9
cannot be activated to induce the caspase cascades that
lead to apoptosis [8,9]. MiR-1 induces apoptosis and tar-
gets PTMA. PTMA is an apoptotic inhibitor, and knock
down of PTMA expression levels is not enough to
induce cell apoptosis. Therefore, miR-1-induced apopto-
sis is likely to alter the expression of other pro-apoptotic
proteins. We found an up regulation of some pro-apop-
totic proteins (HTRA, SMAC, p53, TNF-R1, TNF-R2,
TRAILR-1, TNF-alpha, TNF-beta) expression in miR-1
transfected cells (unpublished data). MicroRNA and
A 
 
 
 
B 
Figure 4 Luciferase assay demonstrates that miR-1 directly
targets PTMA 3’ UTR. (A) Schematic representation of the miR-1
targeting sequences that complement with the 3’ UTR of PTMA
mRNA. The PTMA 3’UTR (+779~801 and +973 ~ +997 nt, miR-1
predictive binding site) were cloned into pmirGLO luciferase vector
to generate pmir-PTMA#1-wt and pmir-PTMA#2-wt. The miR-1 seed
region complementary sequences were mutated and named as
pmir-PTMA#1-mut and pmir-PTMA#2-mut. (B) NPC-TW01 cells were
transfected with miR-1 or without any microRNA. NPC-TW01 cells
were then transfected with pmirGLO empty vector, pmir-PTMA#1-
wt, pmir-PTMA#2-wt, pmir-PTMA#1-mut or pmir-PTMA#2-mut.
Luciferase assays were performed after 36 hours of transfection. The
results indicate that miR-1 directly binds to the PTMA mRNA 3’UTR
and impairs PTMA expression in NPC-TW01 cells. (*Comparison
between two groups as indicated, p < 0.05. Error bars correspond
to mean ± SD)
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Figure 5 PTMA siRNA and miR-1 accelerate the apoptotic process in cells were treated with actinomycin D. From top to bottom:
untransfected NPC-TW01 cells (blank), transfection reagent only (mock), transfection reagent and negative control siRNA (Neg-si), transfection
reagent and PTMA siRNA (PTMA-si), transfection reagent and miR-negative control (miR-neg) and transfection reagent and miR-1 (miR-1).
Actinomycin D apoptotic inducer was added to culture media to a final concentration of 5 μM after 48 hours of transfection. Cells were
subsequently observed by time-lapse microscopy (A). The time above each photograph represents the specific time that cells were transfected
with microRNA, siRNA or control. (B) Cell viability was quantitated by MTT assay. The experimental conditions of the MTT assay were identical to
those during time-lapse microscopy observation. Transfection of PTMA siRNA or miR-1 accelerated the apoptotic process after the NPC-TW01
cells were treated with actinomycin D apoptotic inducer.
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Page 9 of 10pathway database analysis reveals that miR-1 indirectly
regulates those pro-apoptotic protein expressions. We
will verify the pathway network between miR-1 and
those pro-apoptotic proteins in the near future.
Conclusions
We have demonstrated that exogenous expression of
miR-1 can induce apoptosis in some cell lines. This is a
model of microRNA-induced cell apoptosis. PTMA is
one of miR-1 target genes that involve in apoptosis.
PTMA siRNA and miR-1 can accelerate the apoptotic
process in NPC-TW01 cells when cells are treated with
apoptotic inducers. The apoptotic inducers: actinomycin
D, camptothecin and etoposide are also as chemother-
apy drugs in clinical cancer therapy so miR-1 and
PTMA siRNA may have potential applications in assist-
ing cancer therapy.
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